Literature DB >> 34230573

Perivascular vital cells in the ablation center after multibipolar radiofrequency ablation in an in vivo porcine model.

F G M Poch1, C A Neizert2, B Geyer2, O Gemeinhardt3, S M Niehues3, J L Vahldiek3, K K Bressem3, K S Lehmann2.   

Abstract

Multibipolar radiofrequency ablation (RFA) is an advanced ablation technique for early stage hepatocellular carcinoma and liver metastases. Vessel cooling in multibipolar RFA has not been systematically investigated. The objective of this study was to evaluate the presence of perivascular vital cells within the ablation zone after multibipolar RFA. Multibipolar RFA were performed in domestic pigs in vivo. Three internally cooled bipolar RFA applicators were used simultaneously. Three experimental settings were planned: (1) inter-applicator-distance: 15 mm; (2) inter-applicator-distance: 20 mm; (3) inter-applicator-distance: 20 mm with hepatic inflow occlusion (Pringle maneuver). A vitality staining was used to analyze liver cell vitality around all vessels in the ablation center with a diameter > 0.5 mm histologically. 771 vessels were identified. No vital tissue was seen around 423 out of 429 vessels (98.6%) situated within the central white zone. Vital cells could be observed around major hepatic vessels situated adjacent to the ablation center. Vessel diameter (> 3.0 mm; p < 0.05) and low vessel-to-ablation-center distance (< 0.2 mm; p < 0.05) were identified as risk factors for incomplete ablation adjacent to hepatic vessels. The vast majority of vessels, which were localized in the clinically relevant white zone, showed no vital perivascular cells, regardless of vessel diameter and vessel type. However, there was a risk of incomplete ablation around major hepatic vessels situated directly within the ablation center. A Pringle maneuver could avoid incomplete ablations.

Entities:  

Year:  2021        PMID: 34230573     DOI: 10.1038/s41598-021-93406-2

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  37 in total

Review 1.  Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors.

Authors:  Stefaan Mulier; Yicheng Ni; Jacques Jamart; Theo Ruers; Guy Marchal; Luc Michel
Journal:  Ann Surg       Date:  2005-08       Impact factor: 12.969

2.  Current strategies in interventional oncology of colorectal liver metastases.

Authors:  Tatjana Gruber-Rouh; Christian Marko; Axel Thalhammer; Nour-Eldin Nour-Eldin; Marcel Langenbach; Martin Beeres; Nagy N Naguib; Stephan Zangos; Thomas J Vogl
Journal:  Br J Radiol       Date:  2016-05-26       Impact factor: 3.039

3.  Histopathologic comparison of monopolar versus no-touch multipolar radiofrequency ablation to treat hepatocellular carcinoma within Milan criteria.

Authors:  Olivier Seror; Gisèle N'Kontchou; Jeanne Tran Van Nhieu; Yacine Rabahi; Pierre Nahon; Alexis Laurent; Jean Claude Trinchet; Daniel Cherqui; Eric Vicaut; Michel Beaugrand; Nicolas Sellier
Journal:  J Vasc Interv Radiol       Date:  2014-02-12       Impact factor: 3.464

Review 4.  Radiofrequency Ablation and Microwave Ablation in Liver Tumors: An Update.

Authors:  Francesco Izzo; Vincenza Granata; Roberto Grassi; Roberta Fusco; Raffaele Palaia; Paolo Delrio; Gianpaolo Carrafiello; Daniel Azoulay; Antonella Petrillo; Steven A Curley
Journal:  Oncologist       Date:  2019-06-19

5.  Multipolar radiofrequency ablation of hepatic tumors: initial experience.

Authors:  Bernd B Frericks; Jörg P Ritz; Andre Roggan; Karl-Jürgen Wolf; Thomas Albrecht
Journal:  Radiology       Date:  2005-10-19       Impact factor: 11.105

Review 6.  Hepatocellular carcinoma.

Authors:  Josep M Llovet; Andrew Burroughs; Jordi Bruix
Journal:  Lancet       Date:  2003-12-06       Impact factor: 79.321

Review 7.  Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma.

Authors:  Jordi Bruix; Maria Reig; Morris Sherman
Journal:  Gastroenterology       Date:  2016-01-12       Impact factor: 22.682

8.  Minimally invasive surgery versus percutaneous radio frequency ablation for the treatment of single small (≤3 cm) hepatocellular carcinoma: a case-control study.

Authors:  Giulio C Vitali; Alexis Laurent; Sylvain Terraz; Pietro Majno; Nicolas C Buchs; Laura Rubbia-Brandt; Alain Luciani; Julien Calderaro; Philippe Morel; Daniel Azoulay; Christian Toso
Journal:  Surg Endosc       Date:  2015-11-03       Impact factor: 4.584

9.  Radiofrequency ablation for single hepatocellular carcinoma 3 cm or less as first-line treatment.

Authors:  Jun Gao; Shao-Hong Wang; Xue-Mei Ding; Wen-Bing Sun; Xiao-Long Li; Zong-Hai Xin; Chun-Min Ning; Shi-Gang Guo
Journal:  World J Gastroenterol       Date:  2015-05-07       Impact factor: 5.742

10.  The short-term efficacy of no-touch radiofrequency ablation in treating cirrhosis-based small hepatocellular carcinoma.

Authors:  Yuelong Chai; Kun Li; Chang Zhang; Shihan Chen; Kuansheng Ma
Journal:  BMC Cancer       Date:  2019-05-27       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.